Publishing research using ab50332? Please let us know so that we can cite the reference in this datasheet.

ab50332 has been referenced in 5 publications.

  • Kosgodage US  et al. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme. Int J Mol Sci 20:N/A (2018). PubMed: 30597867
  • Lewis HD  et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol 11:189-91 (2015). PubMed: 25622091
  • Tanikawa C  et al. Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. Nat Commun 3:676 (2012). PubMed: 22334079
  • Sharma P  et al. Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression. PLoS Genet 8:e1002934 (2012). WB . PubMed: 23028349
  • Tanikawa C  et al. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response. Cancer Res 69:8761-9 (2009). WB ; Human . PubMed: 19843866

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up